Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06370481

HIV, Equity, and Addiction Training (HEAT) Program

This project is a pilot study to determine the feasibility and acceptability of a telemedicine intervention for substance use disorder service delivery in diverse people living with HIV in Alabama.

Recruiting

Interested in participating?

Request Info

Key information

About this study

The contemporary drug crisis and the COVID-19 pandemic have exposed the complex syndemics of addiction and infectious diseases: rising rates of substance use disorder (SUD) have outpaced our ability to respond with a limited healthcare workforce and public health capacity. SUD is increasing in those living with and at risk for HIV, and infectious consequences of SUD, like hepatitis C, have continued, unmitigated, in rural parts of the U.S. where many states lack Medicaid expansion, syringe service programs, and public health infrastructure to respond to the drug crisis and comorbid infections. Systemic racism and regressive policies in the Deep South criminalize people who use drugs, creating additional barriers to care, HIV prevention, and addiction treatment. As a result, people who use drugs rarely receive comprehensive addiction and HIV treatment. Yet telemedicine has the potential to overcome these barriers and bypass the constraints of a brick-and-mortar clinic to link vulnerable people, including those with HIV, to care. Although telemedicine has become mainstream in recent years, few studies have evaluated telemedicine for SUD in the Deep South from the perspective of patients and providers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Receiving services at HIV clinics in Alabama
  • Reported opioid and/or stimulant misuse
  • 18 years of age or older

Exclusion criteria

  • Receipt of SUD clinical care other than through HIV provider/clinic in the last 3 months
  • Inability to engage in interviews independently without support (e.g., cognitive impairment)
  • Currently psychotic
  • Actively suicidal: presents with a suicide attempt or suicidal ideation

Treatment and study plan

Telemedicine

Other

Routine care administered via telemedicine

Standard of care

Other

Standard of care, as received in HIV clinic settings

Primary outcomes

  1. Percent of participants who have a follow-up healthcare visit

    Time frame: 1 month, 2 months, 3 months

    Follow up visit for care (either telemedicine or in person)

Study contacts

Contact information is provided by the study sponsor or research team.

Ellen F Eaton, MD, MSPH

CONTACT

[email protected]

2059750661

Stephen Tyler O'Rear

CONTACT

[email protected]

2057214060

Sponsors and collaborators

Lead sponsor

University of Alabama at Birmingham

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Acronym: HEAT

Important dates

Study start
2026
Primary completion
2028
Study completion
2029
First posted
Apr 17, 2024
Registry last updated
Feb 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.